The former made use of an established genetically engineered mouse mammary tumor model (GEMM) and took an approach to deplete Hunk by gene knockout, while the latter focused on using human breast cancer cell lines and took an approach to overexpress HUNK [12, 14]. The gene discussed is HUNK; the disease is breast cancer.